Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis.

Autor: Im, Seock-Ah1 moisa@snu.ac.kr, Xu, Binghe2, Li, Wei3, Robson, Mark4, Ouyang, Quchang5, Yeh, Dah-Cherng6, Iwata, Hiroji7, Park, Yeon Hee8, Sohn, Joo Hyuk9, Tseng, Ling-Ming10, Goessl, Carsten11, Wu, Wenting11, Masuda, Norikazu12
Zdroj: Scientific Reports. 5/29/2020, Vol. 10 Issue 1, p1-8. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje